These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29496593)

  • 1. Gut microbiota in kidney disease and hypertension.
    Antza C; Stabouli S; Kotsis V
    Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
    Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
    Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome and hypertension: where are we now?
    Vallianou NG; Geladari E; Kounatidis D
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
    Hsu CN; Tain YL
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota and its relationship with chronic kidney disease.
    Plata C; Cruz C; Cervantes LG; Ramírez V
    Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiota and blood pressure in experimental models.
    Jama HA; Kaye DM; Marques FZ
    Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
    Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
    Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.
    Meijers B; Jouret F; Evenepoel P
    Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.
    Kang Y; Cai Y
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):110-117. PubMed ID: 29102544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
    Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
    Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of gut microbiota in chronic kidney disease.
    Kim SM; Song IH
    Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.